140 related articles for article (PubMed ID: 8275205)
1. Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma.
Herrinton LJ; Weiss NS
Ann Epidemiol; 1993 May; 3(3):308-18. PubMed ID: 8275205
[TBL] [Abstract][Full Text] [Related]
2. Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens.
Cushing KL; Weiss NS; Voigt LF; McKnight B; Beresford SA
Obstet Gynecol; 1998 Jan; 91(1):35-9. PubMed ID: 9464717
[TBL] [Abstract][Full Text] [Related]
3. Risk of endometrial cancer following estrogen replacement with and without progestins.
Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
[TBL] [Abstract][Full Text] [Related]
5. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
6. Estrogens, progesterone, and endometrial cancer.
Jick SS; Walker AM; Jick H
Epidemiology; 1993 Jan; 4(1):20-4. PubMed ID: 8380547
[TBL] [Abstract][Full Text] [Related]
7. Risks of estrogens and progestogens.
L'Hermite M
Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823
[TBL] [Abstract][Full Text] [Related]
8. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
Beresford SA; Weiss NS; Voigt LF; McKnight B
Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
[TBL] [Abstract][Full Text] [Related]
9. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
[TBL] [Abstract][Full Text] [Related]
12. Estrogens, progestogens and endometrial cancer.
Gambrell RD
J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
14. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
Comerci JT; Fields AL; Runowicz CD; Goldberg GL
Gynecol Oncol; 1997 Mar; 64(3):425-30. PubMed ID: 9062144
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal estrogens and progestogens and the incidence of gynecologic cancer.
Weiss NS; Hill DA
Maturitas; 1996 Mar; 23(2):235-9. PubMed ID: 8735361
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and endometrial cancer.
Emons G; Huschmand-Nia A; Krauss T; Hinney B
Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]